Non-invasive treatment of <i>Clostridioides difficile</i> infection with a human-origin probiotic cocktail through gut microbiome-gut metabolome modulations.

ABSTRACT: Clostridioides difficile (C. difficile) is a leading cause of hospital-associated diarrhea, primarily due to gut dysbiosis following antibiotic use. Probiotics have been found to provide several benefits to hosts via modulation of the gut microbiota and their metabolites. However, till now, no conventional probiotics have been clearly proven to be an effective prophylactic option for CDI prevention. Therefore, more studies on developing specific probiotic candidates targeting CDI and improving diversity of probiotics administrated are needed. In this study, a human-origin highly diverse and highly targeted probiotic cocktail (Pro11) containing 11 various probiotic species was developed against C. difficile. Pro11 protected mice against CDI with lower clinical scores an

SUBMITTER: Gurung B 

PROVIDER: S-EPMC11897039 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature